Matches in Wikidata for { <http://www.wikidata.org/entity/Q65370901> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q65370901 description "clinical trial" @default.
- Q65370901 description "ensayu clínicu" @default.
- Q65370901 description "klinisch onderzoek" @default.
- Q65370901 description "клінічне випробування" @default.
- Q65370901 name "Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- Q65370901 name "Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- Q65370901 type Item @default.
- Q65370901 label "Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- Q65370901 label "Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- Q65370901 prefLabel "Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- Q65370901 prefLabel "Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- Q65370901 P1050 Q65370901-2855E100-7B59-45B8-89AC-289BCB587C65 @default.
- Q65370901 P1132 Q65370901-0026373F-ED00-4E4F-9AB3-5D85676C6C25 @default.
- Q65370901 P1476 Q65370901-D88B083E-98DC-48A9-8EC8-6D55DF6D2CF7 @default.
- Q65370901 P17 Q65370901-92B95477-ED05-4DAB-8CD2-F7306DCEA7C2 @default.
- Q65370901 P2899 Q65370901-36650B19-0F5E-4CE5-8134-E406F181F56E @default.
- Q65370901 P3098 Q65370901-B9AD685A-F108-47BA-BCA0-9B04CD4C10B5 @default.
- Q65370901 P31 Q65370901-C5F15289-9B82-4B74-9FE1-193E734DC949 @default.
- Q65370901 P4135 Q65370901-087705EC-113B-479E-91BA-298CF54015B9 @default.
- Q65370901 P4844 Q65370901-3652578F-F284-4DFA-993E-1BB5054C9F25 @default.
- Q65370901 P4844 Q65370901-A9429976-A30E-4A78-A666-245A696EFC74 @default.
- Q65370901 P4844 Q65370901-F339E24B-E7CB-4259-85F8-BA7DF8647538 @default.
- Q65370901 P580 Q65370901-D0879464-D8B1-4FB1-8779-DC663735C3F6 @default.
- Q65370901 P582 Q65370901-7689A07E-7E16-4C84-BA67-E8A95E9AC288 @default.
- Q65370901 P6099 Q65370901-40460CEC-833D-4A90-89EF-F94413DE6DC7 @default.
- Q65370901 P6153 Q65370901-2A8926B0-7186-48DA-BDC4-988FD14B0E73 @default.
- Q65370901 P8363 Q65370901-C17AFD25-F2C1-47B3-8055-F200B51B52CF @default.
- Q65370901 P1050 Q467635 @default.
- Q65370901 P1132 "+93" @default.
- Q65370901 P1476 "Phase II Study of Palifermin With Leuprolide Acetate or Degarelix For the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- Q65370901 P17 Q30 @default.
- Q65370901 P2899 "+18" @default.
- Q65370901 P3098 "NCT01746849" @default.
- Q65370901 P31 Q30612 @default.
- Q65370901 P4135 "+60" @default.
- Q65370901 P4844 Q408524 @default.
- Q65370901 P4844 Q416507 @default.
- Q65370901 P4844 Q907160 @default.
- Q65370901 P580 "2012-12-01T00:00:00Z" @default.
- Q65370901 P582 "2019-12-01T00:00:00Z" @default.
- Q65370901 P6099 Q42824440 @default.
- Q65370901 P6153 Q1808012 @default.
- Q65370901 P8363 Q78089383 @default.